Efficient implementation of the 'non-biopsy approach' for the diagnosis of childhood celiac disease in the Netherlands: a national prospective evaluation 2010-2013

Caroline R Meijer, Joachim J Schweizer, Anne Peeters, Hein Putter, M Luisa Mearin, Caroline R Meijer, Joachim J Schweizer, Anne Peeters, Hein Putter, M Luisa Mearin

Abstract

The aim of this study was (1) to prospectively evaluate the nationwide implementation of the ESPGHAN-guidelines for the diagnosis of celiac disease (CD), (2) to investigate the incidence and clinical presentation of diagnosed childhood CD (0-14 years) in the Netherlands, and (3) to compare the findings with national survey data from 1975 to 1990 and 1993 to 2000 using the same approach. From 2010 to 2013, all practicing paediatricians were invited to report new celiac diagnoses to the Dutch Pediatric Surveillance Unit. Data were collected via questionnaires. A total of 1107 children with newly diagnosed CD were reported (mean age, 5.8 years; range, 10 months-14.9 years; 60.5% female). After the introduction of the non-biopsy approach in 2012, 75% of the diagnoses were made according to the guideline with a significant decrease of 46.3% in biopsies. The use of EMA and HLA-typing significantly increased with 25.8% and 62.1%, respectively. The overall incidence rate of childhood CD was 8.8-fold higher than in 1975-1990 and 2.0-fold higher than in 1993-2000. During the study period, the prevalence of diagnosed CD was 0.14%, far below 0.7% of CD identified via screening in the general Dutch paediatric population. Clinical presentation has shifted towards less severe and extra-intestinal symptoms.Conclusion: ESPGHAN guidelines for CD diagnosis in children were effectively and rapidly implemented in the Netherlands. Incidence of diagnosed CD among children is still significantly rising with a continuous changing clinical presentation. Despite the increasing incidence of diagnoses, significant underdiagnosis still remains. What is Known: • Since 2000 the incidence of diagnosed childhood CD in the Netherlands has shown a steady rise. • The rise in incidence has been accompanied by a changing clinical presentation at diagnosis. What is New: • The ESPGHAN guidelines 2012 for CD diagnosis were effectively and rapidly implemented in the Netherlands. • The incidence of diagnosed childhood CD in the Netherlands has continued to rise significantly during the reported period.

Keywords: Childhood celiac disease; Clinical presentation; Guideline; Implementation; Incidence.

Conflict of interest statement

The authors declare no competing interests.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Incidence of diagnosed childhood celiac disease in three national studies in the Netherlands (n=223 in 1975–1990; n=1017 in 1993–2000, and n=1107 in 2010–2013)

References

    1. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C, Lelgeman M, Mäki M, Ribes-Koninckx C, Ventura A, Zimmer KP, ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–160. doi: 10.1097/MPG.0b013e31821a23d0.
    1. Vriezinga SL, Schweizer JJ, Koning F, Mearin ML. Coeliac disease and gluten-related disorders in childhood. Nat Rev Gastroenterol Hepatol. 2015;12(9):527–536. doi: 10.1038/nrgastro.2015.98.
    1. Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al (2018) Global prevalence of celiac disease: systematic review and meta-analysis. 16(6):823–836
    1. George EK, Mearin ML, van der Velde EA, Houwen RH, Bouquet J, Gijsbers CF, et al. Low incidence of childhood celiac disease in The Netherlands. Pediatr Res. 1995;37(2):213–218. doi: 10.1203/00006450-199502000-00015.
    1. Steens RF, Csizmadia CG, George EK, Ninaber MK, Hira Sing RA, Mearin ML. A national prospective study on childhood celiac disease in the Netherlands 1993-2000: an increasing recognition and a changing clinical picture. J Pediatr. 2005;147(2):239–243. doi: 10.1016/j.jpeds.2005.04.013.
    1. Rosén A, Sandström O, Carlsson A, Högberg L, Olén O, Stenlund H, et al. Usefulness of symptoms to screen for celiac disease? Pediatrics. 2014;133(2):211–218. doi: 10.1542/peds.2012-3765.
    1. Hujoel IA, Van Dyke CT, Brantner T, Larson J, King KS, Sharma A, et al. Natural history and clinical detection of undiagnosed coeliac disease in a North American community. Aliment Pharmacol Ther. 2018;47(10):1358–1366. doi: 10.1111/apt.14625.
    1. Csizmadia CG, Mearin ML, von Blomberg BM, Brand R, Verloove-Vanhorick SP. An iceberg of childhood coeliac disease in the Netherlands. Lancet. 1999;353(9155):813–814. doi: 10.1016/S0140-6736(99)00243-3.
    1. Jansen M, van Zelm M, Groeneweg M, Jaddoe V, Dik W, Schreurs M, Hooijkaas H, Moll H, Escher J. The identification of celiac disease in asymptomatic children: the Generation R Study. J Gastroenterol. 2018;53(3):377–386. doi: 10.1007/s00535-017-1354-x.
    1. Revised criteria for diagnosis of coeliac disease: report of Working Group of European Society for Paediatric Gastroenterology and Nutrition (1990) Arch Dis Child 65:909-11.
    1. Quitadamo P, Papadopoulou A, Wenzl T, Urbonas V, Kneepkens CMF, Roman E, Orel R, Pavkov DJ, Dias JA, Vandenplas Y, Kostovski A, Miele E, Villani A, Staiano A. European pediatricians’ approach to children with GER symptoms: survey of the implementation of 2009 NASPGHAN-ESPGHAN guidelines. J Pediatr Gastroenterol Nutr. 2014;58(4):505–509. doi: 10.1097/MPG.0b013e3182a69912.
    1. Hira Sing RA, Rodrigues Pereira R. Het Nederlands Signaleringscentrum Kindergeneeskunde; een kwaliteitsinstrument voor preventie en onderzoek. Ned Tijdschr Geneeskd. 2002;146:2409–2414.
    1. Dutch Central Bureau of Statistics 2010-2013.
    1. Quitadamo P, Urbonas V, Papadopoulou A, Roman E, Pavkov DJ, Orel R, Dias JA, Kostovski A, Miele E, Villani A, Staiano A. Do pediatricians apply the 2009 NASPGHAN-ESPGHAN guidelines for the diagnosis and management of gastroesophageal reflux after being trained? J Pediatr Gastroenterol Nutr. 2014;59(3):356–359. doi: 10.1097/MPG.0000000000000408.
    1. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;7:797–801. doi: 10.1038/nm0797-797.
    1. Werkstetter KJ, Korponay-Szabó IR, Popp A, Villanacci V, Salemme M, Heilig G, Lillevang ST, Mearin ML, Ribes-Koninckx C, Thomas A, Troncone R, Filipiak B, Mäki M, Gyimesi J, Najafi M, Dolinšek J, Dydensborg Sander S, Auricchio R, Papadopoulou A, Vécsei A, Szitanyi P, Donat E, Nenna R, Alliet P, Penagini F, Garnier-Lengliné H, Castillejo G, Kurppa K, Shamir R, Hauer AC, Smets F, Corujeira S, van Winckel M, Buderus S, Chong S, Husby S, Koletzko S, Socha P, Cukrowska B, Szajewska H, Wyhowski J, Brown N, Batra G, Misak Z, Seiwerth S, Dmitrieva Y, Abramov D, Vandenplas Y, Goossens A, Schaart MW, Smit VTHBM, Kalach N, Gosset P, Kovács JB, Nagy A, Lellei I, Kőbányai R, Khatami K, Monajemzadeh M, Dimakou K, Patereli A, Hansen TP, Kavalar R, Bolonio M, Ramos D, Kogler H, Amann G, Kosova R, Maglio M, Janssens E, Achten R, Frűhauf P, Skálová H, Kirchner T, Petrarca L, Magliocca FM, Martínez F, Morente V, Thanner-Lechner S, Ratschek M, Gasparetto M, Hook L, Canioni D, Wanty C, Mourin A, Laurila K, Vornane M, Friedler VN, Morgenstern SL, Amil Dias J, Carneiro F, João HS, van Biervliet S, Velde SV, Banoub H, Sampson S, Müller AM, Ene A, Rafeey M, Eftekhar Sadat AT. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology. 2017;153(4):924–935. doi: 10.1053/j.gastro.2017.06.002.
    1. Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, Korponay-Szabó IR, ESPGHAN Working Group on Coeliac Disease Diagnosis Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr. 2012;54(2):229–241. doi: 10.1097/MPG.0b013e318216f2e5.
    1. Zevit N, Shamir R. Diagnosis of celiac disease: where are we heading after the ESPGHAN 2012 guidelines? J Pediatr Gastroenterol Nutr. 2014;59(Suppl 1):S13–S15. doi: 10.1097/01.mpg.0000450396.76521.b0.
    1. Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, Shamir R, Troncone R, Auricchio R, Castillejo G, Christensen R, Dolinsek J, Gillett P, Hróbjartsson A, Koltai T, Maki M, Nielsen SM, Popp A, Størdal K, Werkstetter K, Wessels M. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141–156. doi: 10.1097/MPG.0000000000002497.
    1. Donat E, Ramos JM, Sánchez-Valverde F, Moreno A, Martinez MJ, Leis R, Peña-Quintana L, Castillejo G, Fernández S, Garcia Z, Ortigosa L, Balmaseda E, Marugán JM, Eizaguirre FJ, Lorenzo H, Barrio J, Ribes-Koninckx C, SEGHNP Working Group on Coeliac Disease ESPGHAN 2012 guidelines for coeliac disease diagnosis: validation through a retrospective Spanish multicentric study. J Pediatr Gastroenterol Nutr. 2016;62(2):284–291. doi: 10.1097/MPG.0000000000000870.
    1. Ermarth A, Bryce M, Woodward S, et al. Identification of Pediatric Patients With Celiac Disease Based on Serology and a Classification and Regression Tree Analysis. Clin Gastroenterol Hepatol. 2017;15:396–402. doi: 10.1016/j.cgh.2016.10.035.
    1. Rajani S, Huynh HQ, Shirton L, Kluthe C, Spady D, Prosser C, Meddings J, Rempel GR, Persad R, Turner JM. A Canadian study toward changing local practice in the diagnosis of pediatric celiac disease. Can J Gastroenterol Hepatol. 2016;2016:1–7. doi: 10.1155/2016/6234160.
    1. Burger JP, Roovers EA, Drenth JP, Meijer JW, Wahab PJ. Rising incidence of celiac disease in the Netherlands; an analysis of temporal trends from 1995 to 2010. Scand J Gastroenterol. 2014;49:933–941. doi: 10.3109/00365521.2014.915054.
    1. Namatovu F, Sandström O, Olsson C, Lindkvist M, Ivarsson A. Celiac disease risk varies between birth cohorts, generating hypotheses about causality: evidence from 36 years of population-based follow-up. BMC Gastroenterol. 2014;14:59. doi: 10.1186/1471-230X-14-59.
    1. Roma E, Panayiotou J, Karantana H, Constantinidou C, Siakavellas SI, Krini M, Syriopoulou VP, Bamias G. Changing pattern in the clinical presentation of pediatric celiac disease: a 30-year study. Digestion. 2009;80(3):185–191. doi: 10.1159/000227275.
    1. White LE, Merrick VM, Bannerman E, Russell RK, Basude D, Henderson P, et al. The rising incidence of celiac disease in Scotland. Pediatrics. 2013;132:1–8. doi: 10.1542/peds.2013-0932.
    1. Almallouhi E, King KS, Patel B, Wi C, Juhn YJ, Murray JA, Absah I. Increasing incidence and altered presentation in a population-based study of pediatric celiac disease in North America. J Pediatr Gastroenterol Nutr. 2017;65:432–437. doi: 10.1097/MPG.0000000000001532.
    1. Gatti S, Lionetti E, Balanzoni L, Verma AK, Galeazzi T, Gesuita R, et al. Celiac screening team. Increased prevalence of celiac disease in school-age children in Italy. Clin Gastroenterol Hepatol. 2019;18:596–603. doi: 10.1016/j.cgh.2019.06.013.
    1. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93. doi: 10.1053/j.gastro.2009.03.059.
    1. Levinson-Castiel R, Eliakim R, Shinar E, Perets TT, Layfer O, Levhar N, Schvimer M, Marderfeld L, Ben-Horin S, Shamir R. Rising prevalence of celiac disease is not universal and repeated testing is needed for population screening. United European Gastroenterol J. 2019;7(3):412–418. doi: 10.1177/2050640618818227.
    1. DPSU letter.
    1. Ress K, Luts K, Rägo T, Pisarev H, Uibo O. Nationwide study of childhood celiac disease incidence over a 35-year period in Estonia. Eur J Pediatr. 2012;171(12):1823–1828. doi: 10.1007/s00431-012-1835-0.
    1. Iwanczak B, Matusiewicz K, Iwanczak F. Clinical picture of classical, atypical and silent celiac disease in children and adolescents. Adv Clin Exp Med. 2013;22(5):667–673.
    1. Ravikumara M, Tuthill DP, Jenkins HR. The changing clinical presentation of coeliac disease. Arch Dis Child. 2006;91(12):969–971. doi: 10.1136/adc.2006.094045.
    1. Telega G, Bennet TR, Werlin S. Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med. 2008;162(2):164–168. doi: 10.1001/archpediatrics.2007.38.
    1. Garampazzi A, Rapa A, Mura S, Capelli A, Valori A, Boldorini R, Oderda G. Clinical pattern of celiac disease is still changing. J Pediatr Gastroenterol Nutr. 2007;45(5):611–4.37. doi: 10.1097/MPG.0b013e31814c3d79.
    1. McGowan KE, Castiglione DA, Butzner JD. The changing face of childhood celiac disease in north america: impact of serological testing. Pediatrics. 2009;124(6):1572–1578. doi: 10.1542/peds.2008-2373.
    1. Tapsas D, Hollén E, Stenhammar L, Fälth-Magnusson K. The clinical presentation of coeliac disease in 1030 Swedish children: changing features over the past four decades. Dig Liver Dis. 2016;48:16–22. doi: 10.1016/j.dld.2015.09.018.
    1. Van Kalleveen MW, de Meij T, Plötz FB. Clinical spectrum of paediatric coeliac disease: a 10-year single-centre experience. Eur J Pediatr. 2018;177(4):593–602. doi: 10.1007/s00431-018-3103-4.
    1. Popp A, Mäki M. Changing pattern of childhood celiac disease epidemiology: contributing factors. Front Pediatr. 2019;7:357. doi: 10.3389/fped.2019.00357.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera